| Model Number |
MMT-1884 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
Hyperglycemia (1905)
|
| Date of Event |
03/06/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported to medtronic minimed that the customer experienced hyperglycemia with blood glucose value of 479 mg/dl greater than 4 hours.The customer reported hyperglycemia was treated with manual bolus.The event involved product(s) mmt-441ag, mmt-342g, mmt-1884.Troubleshooting was performed.The customer was using the insulin pump within 48 hours of the reported event.The auto mode feature was not active at the time of the event.The customer was unable to get insulin for 4 days.No further patient complications were reported.No product return is required for mmt-441ag, mmt-342g, mmt-1884.
|
| |
|
Additional Manufacturer Narrative
|
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information has been received which was not included in the initial report.The information has been provided in section b5 (updated the summary) with this report.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Updated summary: the customer reported running out of u-500 insulin, resulting in inability to use the insulin pump for the past four days.Insulin was removed from a pen and transferred into the reservoir (res) to determine whether the pump would function properly.The customer called for assistance with restarting and resuming pump use.The pump had not been used within 48 hours of the incident.
|
| |
|
Search Alerts/Recalls
|